Pfizer says money killed AZ deal

Share this article:

Pfizer Chief Financial Officer Frank D'Amelio told an audience at a Goldman Sachs investment conference that the AstraZeneca deal fell apart over money, Bloomberg reports.

AstraZeneca turned down the $117 billion bid Memorial Day weekend, and Pfizer cannot approach the company until three months have lapsed.

Bloomberg reported earlier that perceived personal affronts also doomed Pfizer's overture.

Share this article:
close

Next Article in Business Briefs

Email Newsletters

More in Business Briefs

Avastin pockets another Priority Review label

It's the second for this cancer drug in two weeks.

Court invalidates some healthcare subsidies

The lawsuit has been wending its way through the courts for a while, and, although it is being deliberated in several other venues, the decision is part of a legal dispute that puts patients in the 36 states offering federal exchanges in limbo.

FDA generic division overhaul kicks in

The Food and Drug Administration has been intent on elevating and reorganizing its office of Generic Drugs since 2012.